782475-31-4Relevant academic research and scientific papers
In vivo programming of endogenous antibodies via oral administration of adaptor ligands
Nagano, Masanobu,Carrillo, Nancy,Otsubo, Nobumasa,Hakamata, Wataru,Ban, Hitoshi,Fuller, Roberta P.,Bashiruddin, Nasir K.,Barbas, Carlos F.
, p. 5952 - 5961 (2017)
Vaccination is a reliable method of prophylaxis and a crucial measure for public health. However, the majority of vaccines cannot be administered orally due to their degradation in the harsh gut environment or inability to cross the GI tract. In this stud
ANTI-ANGIOGENIC COMPOUNDS
-
Page/Page column 106, (2008/12/06)
The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
Anti-angiogenic compounds
-
Page/Page column 104, (2008/06/13)
The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
